A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057)
Clinical trial NCT00414050 · COMPLETED
Trial details
- NCT number
- NCT00414050
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-06
- Primary completion
- 2007-10-22
- Enrollment
- 1718
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.